EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

β-Cyclodextrin-Modified Methylene Blue–Alginate Microgels by Droplet Microfluidics for Antibacterial Photodynamic Therapy

Adei Abouhagger iD, Laura Milaknytė iD, Wanessa de Melo iD, Arūnas Stirkė iD, Povilas Šimonis iD

ACS Applied Bio Materials · 17.11.2026

DOI: 10.1021/acsabm.6c01927 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 17.11.2026. Verfasst von Adei Abouhagger und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Functional Materials and Electronics, State Research Institute Center for Physical Sciences and Technology (FTMC), VilniusLT-02300, Lit…. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial photodynamic therapy offers a route to bacterial inactivation that does not depend on conventional resistance mechanisms, and methylene blue (MB) is among the most established photosensitizers. Its efficiency, however, is governed by aggregation state: only monomeric MB generates singlet oxygen efficiently, while the dimers that form within negatively charged carriers such as alginate are photodynamically inactive. Here, we report a droplet-microfluidic platform for fabricating monodisperse MB-loaded calcium alginate microgels and exploit β-cyclodextrin (β-CD) co-encapsulation to control the monomer fraction of the released dye. Internal-gelation flow-focusing produced uniform microgels (∼132 µm; coefficient of variation 2.1%), within which increasing β-CD content progressively raised the monomeric fraction of the released MB, as quantified by the A664/A610 absorbance ratio. Photosensitized ROS generation under 630 nm irradiation, measured with 1,3-diphenylisobenzofuran in a medium that preserves MB aggregation, was 1.9-fold higher for the β-cyclodextrin formulation, and the microgels produced clear, light-dependent killing of Staphylococcus aureus and Escherichia coli. β-Cyclodextrin co-encapsulation significantly enhanced bactericidal activity against S. aureus (p < 0.01), with the same trend in E. coli. By making photosensitizer monomer fraction, dose, and carrier geometry separately measurable and tunable within a single monodisperse platform, this work provides a route toward the rational optimization of photodynamic antibacterial microgels.

Schlagwörter

Stichwörter der Autor:innen

antimicrobial photodynamic therapycalcium alginate microgelsdroplet microfluidicsinclusion complexmethylene bluemonomer–dimer equilibriumphotosensitizer encapsulationsinglet oxygenβ-cyclodextrin

Autor:innen und Institutionen

  • Department of Functional Materials and Electronics, State Research Institute Center for Physical Sciences and Technology (FTMC), VilniusLT-02300, Lithuania.

ORCID-Profile: Adei Abouhagger, Laura Milaknytė, Wanessa de Melo, Arūnas Stirkė, Povilas Šimonis

Zitieren

APA

Abouhagger, A., Milaknytė, L., de Melo, W., Stirkė, A., & Šimonis, P. (2026). β-Cyclodextrin-Modified Methylene Blue–Alginate Microgels by Droplet Microfluidics for Antibacterial Photodynamic Therapy. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.6c01927

Vancouver

Abouhagger A, Milaknytė L, de Melo W, Stirkė A, Šimonis P. β-Cyclodextrin-Modified Methylene Blue–Alginate Microgels by Droplet Microfluidics for Antibacterial Photodynamic Therapy. ACS Applied Bio Materials. 2026. doi:10.1021/acsabm.6c01927

BibTeX
@article{Abouhagger2026,
  author = {Abouhagger, Adei and Milaknytė, Laura and de Melo, Wanessa and Stirkė, Arūnas and Šimonis, Povilas},
  title = {β-Cyclodextrin-Modified Methylene Blue–Alginate Microgels by Droplet Microfluidics for Antibacterial Photodynamic Therapy},
  journal = {ACS Applied Bio Materials},
  year = {2026},
  doi = {10.1021/acsabm.6c01927}
}
Kostenlos starten →